Search results for "hyperhomocysteinemia"

showing 3 items of 33 documents

Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor acti…

1997

A moderate elevation of plasma homocysteine is a risk factor for atherosclerosis and arterial and veinous thrombosis. However, the mechanisms leading to vascular disorders are poorly understood because studies that have investigated the potential atherothrombogenicity of hyperhomocysteinemia in vivo are scarce. Using a rat model, we were the first to show that dietary folic acid deficiency, a major cause of basal hyperhomocysteinemia, is associated with enhanced macrophage-derived tissue factor and platelet activities. We proposed that an homocysteine-induced oxidative stress may account for this hypercoagulable state. To determine the true thrombogenicity of moderate hyperhomocysteinemia a…

medicine.medical_specialtyHyperhomocysteinemiaMethioninebiologybusiness.industryThromboxanemedicine.disease_causemedicine.diseaseBiochemistryLipid peroxidationchemistry.chemical_compoundTissue factorEndocrinologychemistryInternal medicineGeneticsbiology.proteinmedicinePlateletThromboxane-A synthasebusinessMolecular BiologyOxidative stressBiotechnologyThe FASEB Journal
researchProduct

Hyperhomocysteinemia in hemodialysis patients: Is it a risk factor for cardiovascular disease?

2005

medicine.medical_specialtyHyperhomocysteinemiabusiness.industrymedicine.medical_treatmentBiomedical EngineeringHyperhomocysteinemiaMedicine (miscellaneous)BioengineeringMembranes ArtificialGeneral MedicineDiseasemedicine.diseaseBiomaterialsCardiovascular DiseasesRenal DialysisRisk FactorsInternal medicinemedicineHumansHemodialysisRisk factorbusiness
researchProduct

Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis

2010

Introduction: The role that hyperhomocysteinemia (HH) and the C677T mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) play in splanchnic vein thrombosis (SVT) remains unclear due to this unusual thrombotic location. Objective: To analyse the possible association of HH with the C677T mutation in the MTHFR gene in SVT. Material and methods: We determined homocysteine levels and the C677T MTHFR mutation, along with classical cardiovascular risk factors, in 48 patients with SVT (18 Budd-Chiari syndrome, 11 mesenteric vein thrombosis, 19 portal vein thrombosis) and 84 controls. Results: In the univariate analysis, patients with SVT showed statistically higher homocysteine levels (P = …

medicine.medical_specialtyUnivariate analysisHyperhomocysteinemiabiologyHomocysteineCholesterolbusiness.industryHematologyGeneral Medicinemedicine.diseaseGastroenterologyPortal vein thrombosisSurgerychemistry.chemical_compoundVenous thrombosischemistrySplanchnic vein thrombosisInternal medicineMethylenetetrahydrofolate reductasemedicinebiology.proteinbusinessEuropean Journal of Haematology
researchProduct